Their GLP-1 program is relatively new, but the platform itself has years of credibility behind it
the delay allows these mechanisms to activate
Chris Serres: So yeah, I try to stay on top of these studies in part because theres huge, lifesaving implications, especially if you have something that could potentially, you know, be a game changer, which I think, GLP-1s are
And that is the standard of care every patient deserves
In cases of significant nausea, pharmacologic interventions such as prochlorperazine may be used as needed and are preferred over ondansetron
Any suspected adverse reaction to a medicinal product including those used in clinical trials should be reported via the MHRA Yellow Card scheme (available at yellowcard.mhra.gov.uk)